Niacin as a Component of Combination Therapy for Dyslipidemia
- 30 June 2003
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 78 (6), 735-742
- https://doi.org/10.4065/78.6.735
Abstract
No abstract availableKeywords
Funding Information
- Ionis Pharmaceuticals
- National Institutes of Health
This publication has 42 references indexed in Scilit:
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendationsThe American Journal of Cardiology, 2002
- Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in MenArchives of Internal Medicine, 2001
- Lipoprotein(a) and Coronary Heart DiseaseCirculation, 2000
- The Lipid Treatment Assessment Project (L-TAP)Archives of Internal Medicine, 2000
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJama-Journal Of The American Medical Association, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Distribution of lipids in 8,500 men with coronary artery diseaseThe American Journal of Cardiology, 1995